Proposed Data Collection Submitted for Public Comment and Recommendations, 38148-38150 [2024-09852]

Download as PDF 38148 Federal Register / Vol. 89, No. 89 / Tuesday, May 7, 2024 / Notices and annually since 1989. The survey is conducted under authority of Section 306 of the Public Health Service Act (42 U.S.C. 242k). The National Hospital Discharge Survey (NHDS) (OMB No. 0920–0212, Exp. Date 01/31/2019), conducted continuously between 1965 and 2010, was the Nation’s principal source of data on inpatient utilization of short-stay, non-institutional, nonFederal hospitals, and was the principal source of nationally representative estimates on the characteristics of inpatients including lengths of stay, diagnoses, surgical and non-surgical procedures, and patterns of use of care in hospitals in various regions of the country. In 2011, NHDS was granted approval by OMB to expand its content and to change its name to the National Hospital Care Survey (NHCS). In May 2011, recruitment of sampled hospitals for the NHCS began. Hospitals in the NHCS are asked to provide data on all inpatients from their UB–04 administrative claims, or EHRs. Hospital-level characteristics and information about telemedicine usage in the healthcare setting are collected through an Annual Hospital Interview. health care acquired infections and antimicrobial use. Beginning in 2013, in addition to inpatient hospital data, hospitals participating in NHCS were asked to provide data on the utilization of health care services in their ambulatory settings (e.g., EDs and OPDs). Due to low response rates and a high level of missing data, OPD data were not collected in the last approval period (2022, 2023 and 2024). Collection of OPD may resume in future years. Data collected through NHCS are essential for evaluating the health status of the population, for the planning of programs and policy to improve health care delivery systems of the Nation, for studying morbidity trends, and for research activities in the health field. Changes to the data collection survey include the removal of COVID–19 questions from the Annual Hospital Interview (AHI). The burden hours have been reduced due to a decrease in the sample size. The new total annualized burden is 5,826 hours. There is no cost to respondents other than their time to participate. NHCS will continue to provide the same national health-care statistics on hospitals that NHDS provided. Additionally, NHCS collects more information at the hospital level (e.g., volume of care provided by the hospital), which allow for analyses on the effect of hospital characteristics on the quality of care provided. NHCS data collected from UB–04 administrative claims and EHRs include all inpatient discharges, not just a sample. The confidential collection of personally identifiable information (PII) allows NCHS to link episodes of care provided to the same patient in the ED and/or OPD and as an inpatient, as well as link patients to the National Death Index (NDI) to measure post-discharge mortality, and Medicare and Medicaid data to leverage comorbidities. The availability of patient identifiers also makes analysis on hospital readmissions possible. This comprehensive collection of data makes future opportunities for surveillance possible, including analyzing trends and incidence of opioid misuse, acute myocardial infarction, heart failure and stroke, as well as trends and point prevalence of ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Avg. burden per response (in hours) Total burden (in hours) Form name Hospital DHIM or DHIT ..................... Hospital CEO/CFO ............................ Hospital DHIM or DHIT ..................... 123 30 356 1 1 12 1 1 1 123 30 4,272 200 4 1 800 Hospital CEO/CFO ............................ Initial Hospital Intake Questionnaire Recruitment Survey Presentation .... Prepare and transmit UB–04 or State File for Inpatient and Ambulatory (monthly). Prepare and transmit EHR for Inpatient and Ambulatory (quarterly). Annual Hospital Interview ................ 601 1 1 601 Total ........................................... ........................................................... ........................ ........................ ........................ 5,826 Hospital DHIM or DHIT ..................... Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Public Health Ethics and Regulations, Office of Science, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [FR Doc. 2024–09855 Filed 5–6–24; 8:45 am] [60-Day–24–24FA; Docket No. CDC–2024– 0032] BILLING CODE 4163–18–P Proposed Data Collection Submitted for Public Comment and Recommendations khammond on DSKJM1Z7X2PROD with NOTICES Number of responses per respondent Respondents Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of SUMMARY: VerDate Sep<11>2014 15:55 May 06, 2024 Jkt 262001 PO 00000 Frm 00131 Fmt 4703 Sfmt 4703 government information, invites the general public and other federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on an information collection project titled Human-Centered Design Effort on Bringing Guidelines to the Digital Age. This information collection will allow CDC to understand pain points in developing solutions that help develop and implement guidelines that leverage technology to improve patient care. CDC must receive written comments on or before July 8, 2024. DATES: You may submit comments, identified by Docket No. CDC–2024– 0032 by either of the following methods: ADDRESSES: E:\FR\FM\07MYN1.SGM 07MYN1 38149 Federal Register / Vol. 89, No. 89 / Tuesday, May 7, 2024 / Notices • Federal eRulemaking Portal: www.regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–8, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to www.regulations.gov. Please note: Submit all comments through the Federal eRulemaking portal (www.regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–8, Atlanta, Georgia 30329; Telephone: 404–639–7570; Email: omb@ cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of Background and Brief Description information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses; and 5. Assess information collection costs. Given the increased demand to improve clinical guideline development and implementation, a new approach that began with an initiative on Adapting Clinical Guidelines for the Digital Age has been expanded by Guidelines International Network (GIN) North America to implement a future state of guideline development and implementation that leverages advancements in technology. To identify pain points in the process, CDC plans to engage individuals from multiple perspectives in guideline development and implementation in discussion. CDC requests approval for an Existing Collection in Use Without an OMB Control Number for a data collection titled Human-Centered Design Effort on Bringing Guidelines to the Digital Age. CDC will use semi-structured interviews to collect data for this study. The interviews will explore insights about guideline development and implementation as well as pain points in this process. Data will be used to inform the structure of a humancentered design workshop where participants use the pain points identified as starting points for designing solutions. Burden estimates include the time for respondents to be participate in semi-structured interviews. CDC requests OMB approval for an estimated 33 annual burden hours. There is no cost to respondents other than their time to participate. Proposed Project Human-Centered Design Effort on Bringing Guidelines to the Digital Age— Existing Collection in Use Without an OMB Control Number—Office of Public Health Data, Surveillance, and Technology (OPHDST), Centers for Disease Control and Prevention (CDC). ESTIMATED ANNUALIZED BURDEN HOURS Form Name Clinicians ........................................... EHR Vendors .................................... Guideline Developers ........................ Clinician Conversation Guide ........... EHR Vendor Conversation Guide .... Guideline Developer Conversation Guide. Informaticist Conversation Guide ..... Implementer Conversation Guide .... Insurer Conversation Guide ............. Patient/Patient Advocate Conversation Guide. Informaticists ..................................... Implementers .................................... Insurers ............................................. Patient/Patient Advocate ................... khammond on DSKJM1Z7X2PROD with NOTICES Total ........................................... VerDate Sep<11>2014 15:55 May 06, 2024 ........................................................... Jkt 262001 PO 00000 Frm 00132 Fmt 4703 Average burden per response (in hours) Number of responses per respondent Number of respondents Type of respondent Total burden (in hours) 5 2 8 1 1 1 1 1 1 5 2 8 4 9 1 4 1 1 1 1 1 1 1 1 4 9 1 4 ........................ ........................ ........................ 33 Sfmt 4703 E:\FR\FM\07MYN1.SGM 07MYN1 38150 Federal Register / Vol. 89, No. 89 / Tuesday, May 7, 2024 / Notices Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Public Health Ethics and Regulations, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2024–09852 Filed 5–6–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–24–1355; Docket No. CDC–2024– 0022] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Evaluation of the Division of Overdose Prevention Technical Assistance Center. This data collection allows CDC to collect information from partner organizations regarding feedback on their experiences receiving technical assistance. DATES: CDC must receive written comments on or before July 8, 2024. ADDRESSES: You may submit comments, identified by Docket No. CDC–2024– 0022 by either of the following methods: • Federal eRulemaking Portal: www.regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–8, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to www.regulations.gov. Please note: Submit all comments through the Federal eRulemaking portal (www.regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 15:55 May 06, 2024 Jkt 262001 the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–8, Atlanta, Georgia 30329; Telephone: 404–639–7570; Email: omb@ cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses; and 5. Assess information collection costs. Proposed Project Evaluation of the Division of Overdose Prevention Technical Assistance Center (OMB Control No., 0920–1355, Exp. 11/30/202)— Revision—National Center for Injury Prevention and Control (NCIPC), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Centers for Disease Control and Prevention (CDC) is submitting a Revision request for the currently PO 00000 Frm 00133 Fmt 4703 Sfmt 4703 approved Evaluating the Overdose Data to Action TA Hub (OMB Control No. 0920–1355, Exp. Date 11/30/2024) for three years. CDC requests a three-year OMB approval to support the evaluation of technical assistance (TA) provided for the Overdose Data to Action (OD2A) in States (S) and OD2A: Limiting Overdose through Collaborative Actions in Localities (LOCAL) programs. OD2A–S and OD2A: LOCAL are cooperative agreements funded in 2023 to focus on comprehensive and interdisciplinary opioid overdose prevention efforts in 49 state health departments, 39 localities, Puerto Rico, and Washington, DC. Each program consists of two required components—a surveillance component and a prevention component. OD2A recipients implement a combination of activities across nine state strategies and eight local strategies within these components in order to gain access to high quality, complete, and timelier data on opioid prescribing and overdoses and to use those data to inform prevention and response efforts in their jurisdictions. In the previously approved iteration of this data collection, the information collected surrounding OD2A (version 1.0) recipient feedback on their experiences receiving TA proved invaluable in the process of improving TA delivery and overall providing more useful TA. The feedback provided in the original data collection instruments was also used to improve the TA Strategy of the updated iterations of OD2A (including OD2A–S and OD2A: LOCAL) and their recipients. With the information that was collected in the previously approved ICR, CDC can more effectively deliver TA to an almostdoubled recipient group across two programs instead of one and ensure that continuous improvement in TA is occurring. Further information gathering through the two new instruments proposed in this ICR (the Implementation Feedback Form and the Focus Group script), will even more acutely enhance TA perspectives and needs to effectively and responsibly utilize the DOP TA Center resource. Training and technical assistance (TA) is essential to building knowledge and strengthening the capacity of recipients to implement and evaluate OD2A program strategies. CDC will develop and deploy a TA hub (hereafter referred to as the DOP TA Center) to deliver comprehensive technical assistance and training to support the successful implementation and evaluation of surveillance and prevention activities. The DOP TA Center is designed to enhance the efficiency, coordination, and E:\FR\FM\07MYN1.SGM 07MYN1

Agencies

[Federal Register Volume 89, Number 89 (Tuesday, May 7, 2024)]
[Notices]
[Pages 38148-38150]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09852]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60-Day-24-24FA; Docket No. CDC-2024-0032]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies the opportunity to comment on a proposed information 
collection, as required by the Paperwork Reduction Act of 1995. This 
notice invites comment on an information collection project titled 
Human-Centered Design Effort on Bringing Guidelines to the Digital Age. 
This information collection will allow CDC to understand pain points in 
developing solutions that help develop and implement guidelines that 
leverage technology to improve patient care.

DATES: CDC must receive written comments on or before July 8, 2024.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0032 by either of the following methods:

[[Page 38149]]

     Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to www.regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (www.regulations.gov) or by U.S. mail to the address listed 
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Human-Centered Design Effort on Bringing Guidelines to the Digital 
Age--Existing Collection in Use Without an OMB Control Number--Office 
of Public Health Data, Surveillance, and Technology (OPHDST), Centers 
for Disease Control and Prevention (CDC).

Background and Brief Description

    Given the increased demand to improve clinical guideline 
development and implementation, a new approach that began with an 
initiative on Adapting Clinical Guidelines for the Digital Age has been 
expanded by Guidelines International Network (GIN) North America to 
implement a future state of guideline development and implementation 
that leverages advancements in technology. To identify pain points in 
the process, CDC plans to engage individuals from multiple perspectives 
in guideline development and implementation in discussion. CDC requests 
approval for an Existing Collection in Use Without an OMB Control 
Number for a data collection titled Human-Centered Design Effort on 
Bringing Guidelines to the Digital Age.
    CDC will use semi-structured interviews to collect data for this 
study. The interviews will explore insights about guideline development 
and implementation as well as pain points in this process. Data will be 
used to inform the structure of a human-centered design workshop where 
participants use the pain points identified as starting points for 
designing solutions. Burden estimates include the time for respondents 
to be participate in semi-structured interviews. CDC requests OMB 
approval for an estimated 33 annual burden hours. There is no cost to 
respondents other than their time to participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total  burden
      Type of respondent            Form Name       respondents    responses per   response  (in    (in hours)
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Clinicians....................  Clinician                      5               1               1               5
                                 Conversation
                                 Guide.
EHR Vendors...................  EHR Vendor                     2               1               1               2
                                 Conversation
                                 Guide.
Guideline Developers..........  Guideline                      8               1               1               8
                                 Developer
                                 Conversation
                                 Guide.
Informaticists................  Informaticist                  4               1               1               4
                                 Conversation
                                 Guide.
Implementers..................  Implementer                    9               1               1               9
                                 Conversation
                                 Guide.
Insurers......................  Insurer                        1               1               1               1
                                 Conversation
                                 Guide.
Patient/Patient Advocate......  Patient/Patient                4               1               1               4
                                 Advocate
                                 Conversation
                                 Guide.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............              33
----------------------------------------------------------------------------------------------------------------



[[Page 38150]]

Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-09852 Filed 5-6-24; 8:45 am]
BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.